Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome

Oddo, Salvatore, Billings, Lauren, Kesslak, J.Patrick, Cribbs, David H., LaFerla, Frank M.·2004·Neuron

Cited by (109)

Items 101–109 of 109

  1. Integrated biology approach reveals molecular and pathological interactions among Alzheimer’s Aβ42, Tau, TREM2, and TYROBP in Drosophila models
    Sekiya, Michiko, Wang, Minghui, Fujisaki, Naoki, Sakakibara, Yasufumi, Quan, Xiuming, Ehrlich, Michelle E., De Jager, Philip L., Bennett, David A., Schadt, Eric E., Gandy, Sam et al. · 2018 · Genome Medicine
  2. The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice
    Ou-Yang, Ming-Hsuan, Van Nostrand, William E · 2013 · Journal of Neuroinflammation
  3. Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid β-Derived Neurotoxins
    Lambert, Mary, Velasco, Pauline, Viola, Kirsten, Klein, William · 2009 · CNS & Neurological Disorders - Drug Targets
  4. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation
    Koller, Emily J., Ibanez, Kristen R., Vo, Quan, McFarland, Karen N., Gonzalez De La Cruz, Elsa, Zobel, Lillian, Williams, Tristan, Xu, Guilian, Ryu, Daniel, Patel, Preya et al. · 2022 · Neuropathology and Applied Neurobiology
  5. Clinical immunologic approaches for the treatment of Alzheimer's disease
    Solomon, Beka · 2007 · Expert Opinion on Investigational Drugs
  6. Genetic and pharmacological evidence of intraneuronal Aβ accumulation in APP transgenic mice
    Philipson, Ola, Lannfelt, Lars, Nilsson, Lars N.G. · 2009 · FEBS Letters
  7. Increase in Tau Pathology in P290S <i>Mapt</i> Knock-In Mice Crossed with <i>App</i> <sup>NL-G-F</sup> Mice
    Huang, Melissa, Macdonald, Jennifer, Lavenir, Isabelle, Chen, Renren, Craxton, Molly, Slavik-Smith, Elizabeth, Davies, Stephen W., Goedert, Michel · 2022 · eneuro
  8. Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau
    Zampar, Silvia, Wirths, Oliver · 2021 · International Journal of Molecular Sciences
  9. AD Vaccines: Conclusions and Future Directions
    Wisniewski, Thomas · 2009 · CNS &amp; Neurological Disorders - Drug Targets